Current Investments

Gil Kliman, M.D., focuses on life sciences investing with a special interest in medical devices. He is responsible for a broad portfolio of life sciences companies, including Archus Orthopedics, Epocrates, Glaukos, Neuropace, Ophthonix, and ReVision Optics. He was one of the early lead investors in IntraLase, an ophthalmic laser company which went public in 2004 and was acquired by Advanced Medical Optics (NYSE: EYE) for $808MM in 2007.

Prior to InterWest Partners, Dr. Kliman was a healthcare investor at TA Associates and at Norwest Venture Capital. As a practicing ophthalmologist he was the former west coast director of LCA Vision, and served as an assistant professor at Tufts New England Eye Center.

Dr. Kliman received his B.A. from Harvard University, M.D. from the University of Pennsylvania and M.B.A. from Stanford University.

A Word from Gil

"Over the last 20 years I have had the privilege of diverse life experiences as a practicing physician, start-up company founder, and technology venture capitalist. I most enjoy being on the front edge of new technology waves, looking over the horizon for non-obvious opportunities... What I find exciting is working alongside visionary entrepreneurs, thinking outside the box, and helping to identify creative strategies to make pioneering ventures even more successful."